Details for 2019163940

Up to date per 01.04.2026

Actions

Title / Product Name

SGLT2 INHIBITOR 1-CHLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3- YLOXY)-BENZYL]-BENZENE IN KOMBINATION MIT INSULIN ZUR VERWENDUNG IN EINER METHODE ZUR REDUKTION DES RISIKOS EINER HYPOGLYKÄMIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019163940

EP Publication Number

3539540

E-Number

1751691

Language

PCT Number

Publication Date

18.09.2019 A

18.12.2024 B1

Registration Date

18.12.2024

AT Publication Date

15.01.2025

Application Date

07.11.2011

Registration Number

Priorities

08.11.2010

10190303

17.01.2011

11151059

IPC

A61K 31/341 20060101AFI20240927BHEP

Maximum Duration of Protection

07.11.2031

Owner

Boehringer Ingelheim International GmbHBinger Strasse 173 55216 Ingelheim am RheinDE

Representative

No representatives present

Inventor

GREMPLER, RolfBoehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173 55216 INGELHEIM AM RHEINDE

JOHANSEN, Odd-ErikBoehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173 55216 INGELHEIM AM RHEINDE

KLEIN, ThomasBoehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173 55216 INGELHEIM AM RHEINDE

LUIPPOLD, GerdBoehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173 55216 INGELHEIM AM RHEINDE

MARK, MichaelBoehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173 55216 INGELHEIM AM RHEINDE

Information about Fees